The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis

Yukio Tonozuka, Yoshihide Kakimoto|Cancer Chemotherapy and Pharmacology|2023

Cited by 9